Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Viola Regondi
Early Immune Modulation by Single-Agent Trastuzumab as a Marker of Trastuzumab Benefit
British Journal of Cancer
Cancer Research
Oncology
Related publications
Trastuzumab (Herceptin)
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Trastuzumab Cardiotoxiciy: The Age-Old Balance of Risk and Benefit
British Journal of Cancer
Cancer Research
Oncology
Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Trastuzumab: A Cardiologist’s Perspective
Current Oncology
Oncology
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Oncologist
Cancer Research
Medicine
Oncology
Current Perspective – Trastuzumab
European Journal of Cancer
Cancer Research
Oncology
Trastuzumab as Adjuvant Treatment for Early Stage HER2-positive Breast Cancer — A 10 Year History
Nowotwory
Cancer Research
Oncology
Dual HER2 Blockade Versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal of Oncology
Oncology
Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group
Current Oncology
Oncology
